| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aab27872ff881431919b3491fa9b70b4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4458
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4458
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 |
| filingDate |
2014-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9658d6d38d5d055e3348d29d8fa41b80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fc41eb2873afac05e11ed05c699693a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_367739bf899c520dc5ca09c0878a65ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_701cae63af6a25ae84cff5d9ec382f5e |
| publicationDate |
2016-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20160096184-A |
| titleOfInvention |
Prophylactic and therapeutic agent for attention-deficit/hyperactivity disorder |
| abstract |
1- (benzofuran-2-yl) -2-propylaminopentane or a pharmacologically acceptable acid addition salt thereof has already been shown to exert an excellent action effect as an antidepressant drug, a psychotropic drug, an anti-Parkinson's disease and an anti- Is known. However, it has not been known that this compound is effective in the prevention and treatment of lack of attention ยท multifunctional disorder (ADHD). The present invention reveals that this 1- (benzofuran-2-yl) -2-propylaminopentane or a pharmacologically acceptable acid addition salt thereof is newly effective for the prevention or treatment of ADHD and completes the present invention . |
| priorityDate |
2013-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |